Celularity Inc. Deferred Tax Assets, Goodwill and Intangible Assets
Celularity Inc. (CELU) had Deferred Tax Assets, Goodwill and Intangible Assets of $3.03 million as of 2024-12-31, per its 10-K filed 2026-04-30.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets · last filed 2026-04-30
- 2024-12-31: Deferred Tax Assets, Goodwill and Intangible Assets $3.03M.
- 2023-12-31: Deferred Tax Assets, Goodwill and Intangible Assets $3.44M.
- 2022-12-31: Deferred Tax Assets, Goodwill and Intangible Assets $3.90M.
- 2021-12-31: Deferred Tax Assets, Goodwill and Intangible Assets $4.47M.
| Period end | Deferred Tax Assets, Goodwill and Intangible Assets |
|---|---|
| 2024-12-31 | $3.03M 10-K · filed 2026-04-30 |
| 2023-12-31 | $3.44M 10-K · filed 2025-05-08 |
| 2022-12-31 | $3.90M 10-K · filed 2024-07-30 |
| 2021-12-31 | $4.47M 10-K · filed 2023-03-31 |
| 2020-12-31 | $4.54M 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |